Helix Biopharma Corp.
HBP.TO
TSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.42M | -3.02M | -3.47M | -3.72M | -6.89M |
| Total Depreciation and Amortization | 2.80K | 4.90K | 5.60K | 7.10K | 8.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 89.70K | 145.10K | 231.40K | 17.10K | 2.51M |
| Change in Net Operating Assets | -4.20K | 205.00K | 248.70K | 963.60K | 1.56M |
| Cash from Operations | -2.33M | -2.66M | -2.99M | -2.74M | -2.81M |
| Capital Expenditure | 0.00 | 0.00 | -1.40K | -1.40K | -2.90K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 7.70K | 13.60K | 13.60K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 6.30K | 12.20K | 10.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.33M | 1.76M | 4.45M | 2.80M | 3.90M |
| Repurchase of Common Stock | -12.00K | -12.00K | -1.00K | -1.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.87M | 1.25M | 3.16M | 1.97M | 2.77M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 18.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.54M | -1.41M | 181.70K | -755.00K | -11.00K |